Content 30/08/2019 Space is the Next Frontier for Global Pharma Episode six with Jana Stoudemire, Chief Commercialisation Officer, Space Tango
Content 30/08/2019 The Next Generation of Gene Therapy: A Panoramic View of the New... Episode five with Jessica Carmen, Consultant, Pullan Consulting
Content 22/08/2019 Breaking New Ground: The Why Behind the Nurse Educator Playbook Episode four with Linda S. Barnes, Principal, Linda S. Barnes Consulting
Content 06/08/2019 Advanced Therapies Opportunities in Europe An overview of clinical, investment and market approval activity in Europe
Content 01/08/2019 Translating Scientific and Technology Innovations from Academic... An unmissable interview with Dr Bruce Levine, Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania
Content 03/07/2019 How an Italian Start-up Became the First Company to File a... Episode three with Dr Luca Alberici, Chief Business Officer, MolMed
Content 25/06/2019 Technology Review: Gene Editing Edition one of Phacilitate’s technology review series examines gene editing approaches by viral and non-viral methods and where to access ...
Content 25/06/2019 The Next Chapter Starts Here and Ends with a Cure Episode two with Nicole Gularte, Patient Advocate, Fight for Cures
Content 23/06/2019 Patient Access and Delivery of Advanced Therapies - Part Two An interview with Dr Matthew Frigault, Instructor and Clinical Assistant in Medicine, Massachusetts General Hospital
Content 20/06/2019 The Power of Perseverance: How Dendreon Bounced Back Episode one with Dwayne Soisson, Senior Director Operations, Dendreon
Content 30/05/2019 ASGCT 2019: Patients are Top Priority Amanda Kendall, Phacilitate's Head of Community, gives her first-hand account of ASGCT 2019
Content 28/05/2019 Are We Ready for a $5m Gene Therapy? Episode two of the Phacilitate Leaders World super plenary sessions with Dave Lennon, President of AveXis, Inc
Content 28/05/2019 Advanced Therapies: Cost-effective but Unaffordable? Episode three of the Phacilitate Leaders World super plenary sessions with Michael Meyers, Head of Investment Banking at T.R. Winston ...
Content 24/05/2019 Uncovering Innovation: Phacilitate’s Trip to Israel Phacilitate's Jeremy Roden and David Green ventured out to Tel Aviv to lift the lid on the biotech and advanced therapies innovation across the...
Content 20/05/2019 Five Take-aways from the Advanced Therapies Network Investment Event Phacilitate's Kim Barnes gives her account of the Advanced Therapies Network investment meeting in London
